Lysosomal proteolysis is the primary degradation pathway for cytosolic ferritin and cytosolic ferritin degradation is necessary for iron exit

Antioxidants and Redox Signaling

Volumn 13, Issue 7, 2010, Pages 999-1009

  Zhang, Yinghui ^a,b,c   Mikhael, Marc ^d   Xu, Dongxue ^a,e   Li, Yiye ^a   Soe Lin, Shan ^d   Ning, Bo ^a   Li, Wei ^f   Nie, Guangjun ^a   Zhao, Yuliang ^a,f   Ponka, Prem ^d  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c XIZANG MINZU UNIVERSITY   (China)

^d MCGILL UNIVERSITY   (Canada)

^e JILIN UNIVERSITY   (China)

^f INSTITUTE OF HIGH ENERGY PHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSOLIC FERRITIN; FERRIC AMMONIUM CITRATE; FERRITIN; IRON; IRON BINDING PROTEIN; LEUPEPTIN; LYSOSOMAL PROTEASE; MITOCHONDRIAL FERRITIN; PROTEASOME; PROTEINASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; IRON KINETICS; IRON STORAGE; IRON TRANSPORT; LYSOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; WILD TYPE;

CELL LINE; CYTOSOL; FERRIC COMPOUNDS; FERRITINS; HUMANS; IRON; LEUPEPTINS; LYSOSOMES; MITOCHONDRIA; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; QUATERNARY AMMONIUM COMPOUNDS;

EID: 77955871827     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3129     Document Type: Article

References (55)

1. Aisen P, Wessling-Resnick M, and Leibold EA. Iron metabolism. Curr Opin Chem Biol 3: 200-206, 1999.
2. Alcindor T and Bridges KR. Sideroblastic anaemias. Br J Haematol 116: 733-743, 2002.
3. Arosio P, Ingrassia R, and Cavadini P. Ferritins: A family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 1790: 589-599, 2009.
4. Bridges KR. Ascorbic acid inhibits lysosomal autophagy of ferritin. J Biol Chem 262: 14773-14778, 1987.
5. Burdon KP, Sharma S, Chen CS, Dimasi DP, Mackey DA, and Craig JE. A novel deletion in the FTL gene causes hereditary hyperferritinemia cataract syndrome (HHCS) by alteration of the transcription start site. Hum Mutat 28: 742, 2007.
6. Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, Rolandi V, Biasiotto G, Drysdale J, and Arosio P. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood 101: 1996-2000, 2003.
7. Corsi B, Cozzi A, Arosio P, Drysdale J, Santambrogio P, Campanella A, Biasiotto G, Albertini A, and Levi S. Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. J Biol Chem 277: 22430-22437, 2002.
8. Cozzi A, Santambrogio P, Corsi B, Campanella A, Arosio P, and Levi S. Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder. Neurobiol Dis 23: 644-652, 2006.
9. Domenico ID, Vaughn MB, Li L, Bagley D, Musci G, Ward DM, and Kaplan J. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J 25: 5396-5404, 2006.
10. Domenico ID, Ward DM, and Kaplan J. Specific iron chela-tors determine the route of ferritin degradation. Blood 114: 4546-4551, 2009.
11. DrysdaleJ,Arosio P, Invernizzi R,CazzolaM, Volz A,Corsi B, Biasiotto G, and Levi S. Mitochondrial ferritin: A new player in iron metabolism. Blood Cells Mol Dis 29: 376-383, 2002.
12. Eisenstein RS. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 20: 627-662, 2000.
13. Fleming MD. The genetics of inherited sideroblastic anemias. Semin Hematol 39: 270-281, 2002.
14. Garner B, Li W, Roberg K, and Brunk UT. On the cytoprotec-tive role of ferritin in macrophages and its ability to enhance lysosomal stability. Free Radical Research 27: 487-500, 1997.
15. Garner B, Roberg K, and Brunk UT. Endogenous ferritin protects cells with iron-laden lysosomes against oxidative stress. Free Radical Research 29: 103-114, 1998.
16. Girelli D, Corrocher R, Bisceglia L, Olivieri O, De Franceschi L, Zelante L, and Gasparini P. Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: A mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation"). Blood 86: 4050-4053, 1995.
17. Goralska M, Nagar S, Fleisher LN, and McGahan MC. Differential degradation of ferritin H-and L-chains: Accumulation of L-chain-rich ferritin in lens epithelial cells. Invest Ophthalmol Vis Sci 46: 3521-3529, 2005.
18. Harrison PM and Arosio P. The ferritins: Molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275: 161-203, 1996.
19. Harrison PM, Hoy TG, Macara IG, and Hoare RJ. Ferritin iron uptake and release. Structure-function relationships. Biochem J 143: 445-451, 1974.
20. Ismail AR, Lachlan KL, Mumford AD, Temple IK, and Hodgkins PR. Hereditary hyperferritinemia cataract syndrome: Ocular, genetic, and biochemical findings. Eur J Ophthalmol 16: 153-160, 2006.
21. Jin W, Takagi H, Pancorbo B, and Theil EC. "Opening" the ferritin pore for iron release by mutation of conserved amino acids at interhelix and loop sites. Biochemistry 40: 7525-7532, 2001.
22. Kidane TZ, Sauble E, and Linder MC. Release of iron from ferritin requires lysosomal activity. Am J Physiol Cell Physiol 291: C445-C455, 2006.
23. Kurz T and Brunk UT. Autophagy of HSP70 and chelation of lysosomal iron in a non-redox-active form. Autophagy 5: 93-95, 2009.
24. Kwok JC and Richardson DR. Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: Inhibition of the ferritin iron mobilization pathway. Mol Pharmacol 63: 849-861, 2003.
25. Kwok JC and Richardson DR. Examination of the mecha-nism(s) involved in doxorubicin-mediated iron accumulation in ferritin: Studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents. Mol Pharmacol 65: 181-195, 2004.
26. Lee DH and Goldberg AL. Proteasome inhibitors: Valuable new tools for cell biologists. Trends Cell Biol 8: 397-403, 1998.
27. Leibold EA and Munro HN. Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5' untranslated region of ferritin heavy-and light-subunit mRNAs. Proc Natl Acad Sci USA 85: 2171-2175, 1988.
28. Levi S, Corsi B, Bosisio M, Invernizzi R, Volz A, Sanford D, Arosio P, and Drysdale J. A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem 276: 24437-24440, 2001.
29. Levi S, Santambrogio P, Cozzi A, Rovida E, Corsi B, Tam-borini E, Spada S, Albertini A, and Arosio P. The role of the L-chain in ferritin iron incorporation. Studies of homo and heteropolymers. J Mol Biol 238: 649-654, 1994.
30. Liu X and Theil EC. Ferritins: Dynamic management of biological iron and oxygen chemistry. Acc Chem Res 38: 167-175, 2005.
31. Lu Z, Nie G, Li Y, Soe-Lin S, Tao Y, Cao Y, Zhang Z, Liu N, Ponka P, and Zhao B. Overexpression of mitochondrial fer-ritin sensitizes cells to oxidative stress via an iron-mediated mechanism. Antioxid Redox Signal 11: 1791-1803, 2009.
32. May A and Fitzsimons E. Sideroblastic anaemia. Baillieres Clin Haematol 7: 851-879, 1994.
33. Mehlhase J, Sandig G, Pantopoulos K, and Grune T. Oxidation-induced ferritin turnover in microglial cells: role of proteasome. Free Radic Biol Med 38: 276-285, 2005.
34. Meriin A, Gabai V, Yaglom J, Shifrin V, and Sherman M. Pro-teasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis. J Biol Chem 273: 6373, 1998.
35. Mikulits W, Schranzhofer M, Beug H, and Mullner EW. Post-transcriptional control via iron-responsive elements: The impact of aberrations in hereditary disease. Mutat Res 437: 219-230, 1999.
36. Nie G, Chen G, Sheftel AD, Pantopoulos K, and Ponka P. In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin. Blood 108: 2428-2434, 2006.
37. Nie G, Sheftel AD, Kim SF, and Ponka P. Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis. Blood 105: 2161-2167, 2005.
38. Olejnicka BT, Dalen H, Baranowski MM, and Brunk UT. Starvation-induced autophagocytosis paradoxically decreases the susceptibility to oxidative stress of the extremely oxidative stress-sensitive NIT insulinoma cells. Redox Rep 3: 311-318, 1997.
39. Persson HL, Nilsson KJ, and Brunk UT. Novel cellular defenses against iron and oxidation: Ferritin and autophago-cytosis preserve lysosomal stability in airway epithelium. Redox Report 6: 57-63, 2001.
40. Ponka P, Borova J, Neuwirt J, Fuchs O, and Necas E. A study of intracellular iron metabolism using pyridoxal iso-nicotinoyl hydrazone and other synthetic chelating agents. Biochim Biophys Acta 586: 278-297, 1979.
41. Ponka P and Richardson DR. Can ferritin provide iron for hemoglobin synthesis? Blood 89: 2611-2613, 1997.
42. Ponka P and Schulman HM. Acquisition of iron from transferrin regulates reticulocyte heme synthesis. J Biol Chem 260: 14717-14721, 1985.
43. Radisky DC and Kaplan J. Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibro-blasts. Biochem J 336: 201-205, 1998.
44. Richardson DR, Ponka P, and Vyoral D. Distribution of iron in reticulocytes after inhibition of heme synthesis with suc-cinylacetone: Examination of the intermediates involved in iron metabolism. Blood 87: 3477-3488, 1996.
45. Roberts S and Bomford A. Ferritin iron kinetics and protein turnover in K562 cells. J Biol Chem 263: 19181-19187, 1988.
46. Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443: 780-786, 2006.
47. Rudeck M, Volk T, Sitte N, and Grune T. Ferritin oxidation in vitro: Implication of iron release and degradation by the 20S proteasome. IUBMB Life 49: 451-456, 2000.
48. Santambrogio P, Levi S, Cozzi A, Rovida E, Albertini A, and Arosio P. Production and characterization of recombinant heteropolymers of human ferritin H and L chains. J Biol Chem 268: 12744-12748, 1993.
49. Sheftel AD, Zhang AS, Brown C, Shirihai OS, and Ponka P. Direct interorganellar transfer of iron from endosome to mitochondrion. Blood 110: 125-132, 2007.
50. Takagi H, Shi D, Ha Y, Allewell NM, and Theil EC. Localized unfolding at the junction of three ferritin subunits. A mechanism for iron release? J Biol Chem 273: 18685-18688, 1998.
51. Torti FM and Torti SV. Regulation of ferritin genes and protein. Blood 99: 3505-3516, 2002.
52. Truty J, Malpe R, and Linder MC. Iron prevents ferri-tin turnover in hepatic cells. J Biol Chem 276: 48775-48780, 2001.
53. Vyoral D and Petrak J. Iron transport in K562 cells: A kinetic study using native gel electrophoresis and 59Fe autoradi-ography. Biochim Biophys Acta 1403: 179-188, 1998.
54. Wistow G, Bernstein SL, Wyatt MK, Behal A, Touchman JW, Bouffard G, Smith D, and Peterson K. Expressed sequence tag analysis of adult human lens for the NEIBank Project: over 2000 non-redundant transcripts, novel genes and splice variants. Mol Vis 8: 171-184, 2002. (Pubitemid 36153607)
55. Zhang L, Yu J, Pan H, Hu P, Hao Y, Cai W, Zhu H, Yu AD, Xie X, Ma D, and Yuan J. Small molecule regulators of au-tophagy identified by an image-based high-throughput screen. Proc Natl Acad Sci USA 104: 19023-19028, 2007.